Wszolek Matthew F, Wotkowicz Chad, Libertino John A
Department of Urology, Lahey Clinic, Burlington, MA 01805, USA.
Nat Clin Pract Urol. 2008 Jan;5(1):35-46. doi: 10.1038/ncpuro0963.
In addition to an increased occurrence of small, localized, incidentally discovered renal cell carcinomas (RCCs), there has been an upward trend in the incidence of advanced renal tumors per unit of population and in disease mortality worldwide. As radical nephrectomy remains the standard of care in treating localized RCC, this manuscript focuses on surgical approaches. We defined 'large renal tumors' as those greater than 7 cm or those with venous involvement. We discuss operative strategies in both open and laparoscopic surgery as well as approaches to special circumstances, including patients with tumor thrombus and the indications for nephron-sparing surgery in patients with greater than T2 RCC. The literature pertaining to controversial areas such as preoperative renal artery embolization and the clinical utility of metastectomy and cytoreductive therapy are also reviewed. The theoretical basis and potential applications of neoadjuvant therapy for larger renal tumors is examined as well.
除了偶然发现的小的局限性肾细胞癌(RCC)的发生率增加外,全球范围内单位人口的晚期肾肿瘤发病率和疾病死亡率呈上升趋势。由于根治性肾切除术仍是治疗局限性RCC的标准治疗方法,本文重点关注手术方法。我们将“大肾肿瘤”定义为直径大于7 cm或伴有静脉受累的肿瘤。我们讨论开放手术和腹腔镜手术的手术策略以及特殊情况的处理方法,包括肿瘤血栓患者以及T2期以上RCC患者保留肾单位手术的指征。还回顾了术前肾动脉栓塞等争议领域的文献以及转移灶切除术和减瘤治疗的临床应用。同时也探讨了大肾肿瘤新辅助治疗的理论基础和潜在应用。